0001434647-21-000001.txt : 20210113 0001434647-21-000001.hdr.sgml : 20210113 20210113161549 ACCESSION NUMBER: 0001434647-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210113 DATE AS OF CHANGE: 20210113 EFFECTIVENESS DATE: 20210113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KEMPHARM, INC CENTRAL INDEX KEY: 0001434647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205894398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386231 FILM NUMBER: 21526243 BUSINESS ADDRESS: STREET 1: 1180 CELEBRATION BOULEVARD, SUITE 103 CITY: CELEBRATION STATE: FL ZIP: 34747 BUSINESS PHONE: (321) 939-3416 MAIL ADDRESS: STREET 1: 1180 CELEBRATION BOULEVARD, SUITE 103 CITY: CELEBRATION STATE: FL ZIP: 34747 FORMER COMPANY: FORMER CONFORMED NAME: KEMPHARM INC DATE OF NAME CHANGE: 20080507 D 1 primary_doc.xml X0708 D LIVE 0001434647 KEMPHARM, INC 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL FLORIDA 34747 (321) 939-3416 DELAWARE KEMPHARM INC Corporation true Travis C. Mickle c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Executive Officer Director Promoter R. LaDuane Clifton c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Executive Officer Sven Guenther c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Executive Officer Timothy J. Sangiovanni c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Executive Officer Richard W. Pascoe c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Director Matthew R. Plooster c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Director Joseph B. Saluri c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Director David S. Tierney c/o KemPharm, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL FLORIDA 34747 Director Pharmaceuticals Decline to Disclose 06b false 2021-01-12 false true true true false 0 Cowen & Company, LLC 7616 None None 599 Lexington Avenue New York NY NEW YORK 10022 IL ILLINOIS NY NEW YORK false 31476984 31476984 0 Securities issued in the offering include shares of Series B-2 Preferred Stock and warrants to purchase common stock. Securities were issued in exchange for a portion of the principal amount of outstanding convertible promissory notes. false 4 0 2000000 0 false KEMPHARM, INC /s/ R. LaDuane Clifton R. LaDuane Clifton CFO, Treas & Sec 2021-01-13